Aplastic Anemia
Dr.Vikram Prabhakar (DCP,DNB
Pathology)
APLASTIC ANEMIA
• Reduction in the amount of haemotopoietic
tissue causing inability to produce mature
cells for discharge into the bloodstream.
CLASSIFICATION
• Idiopathic
• Secondary:
idiosyncratic drug reaction
chemical exposure
infectious hepatitis
paroxysmal nocturnal haemoglobinuria
• Constitutional
CLASSIFICATION
CONSTITUTIONAL/CONGENITAL
• Fanconi anemia
• Dyskeratosis Congenita
• Shwachmann-Diamond syndrome
• Inherited amegakaryocytic thrombocytopenia
FANCONI ANEMIA
• Familial
• AR
• M:F=1.3:1
• Onset in 1st decade of life
• Diminished capacity for DNA repair and
increased random chromosome breakage
during mitosis
C/F:
• Facies – microphthalmia,depressed nasal
bridge,epicanthic fold,micrognathia
• Hyperpigmentation, café-au-lait spots
• Absent / hypoplastic thumb
• Skeletal and renal lesions
• Short stature,
• Microcephaly , subnormal intelligence
• Hypogonadism,ano malies of urinary tract
• Predisposition to leukemias
• Poor prognosis
DYSKERATOSIS CONGENITA
• X-linked, AR, AD
• M:F= 4.3:1
• Hyperpigmentation
• Nail dystrophy, early loss of teeth
• Leukoplakia
• Ocular abnormalities: cataract etc
• Short stature but No skeletal/renal lesions
(diff from FA)
DIAMOND BLACKFAN SYNDROME
• Congenital pure red cell aplasia
• AD, AR, Sporadic
• Familial in 15 %
• 90 % diagnosed in 1st year of life
• Intrinsic defect in RBC, early apoptosis
• Macrocytic anemia, reticulocytopenia,
absence of RBC precursors in an otherwise
normocellular bone marrow
DIAMOND BLACKFAN SYNDROME
• Eye - Wide set eyes, blue
sclera,glaucoma,epicanthic
fold,cataract,strabismus
• Thick upper,cleft lip palate in some cases
• lip,intelligent expression
• Upperlimb anomalies – flattening of thenar
eminence, Triphalangeal thumb
C/F:
• Profound anemia at 2-6 months of age
• Short stature
• Renal anomalies and hypogonadism maybe
present
ACQUIRED APLASTIC ANEMIA -
CAUSES
• Radiation
• Drugs and chemicals
- chemotherapy
- benzene
- chloramphenicol
- antiepileptics
• Viruses:
- CMV
- EBV
- Hep B, C,D
- HIV
• Immune diseases:
- eosinophilic fascitis
- thymoma
• Pregnancy
• PNH
• Marrow replacement:
- leukemia
- myelofibrosis
- myelodysplasia
PATHOPHYSIOLOGY
• Direct destruction of hematopoietic
progenitors
• Disruption of marrow micro-environment
(fibroblast and monocyte signaling pathway)
• Immune –mediated suppression of marrow
elements Cytotoxic T cells in blood and
marrow release gamma IFN and TNF -> inhibit
early and late progenitor cells
Pathology:
• Hallmark: peripheral pancytopenia with
hypoplastic/ aplastic bone marrow
CLINICAL FEATURES
RBC (anemia)
• Progressive and persistent pallor
• Anemia related symptoms
WBC (Leucopenia/neutropenia)
• Prone to infections - Pyodermas, OM,
pneumonia, UTI, GI infections, sepsis
Platelets (Thrombocytopenia)
• Petechiae, purpura, ecchymoses
• Hematemesis, hematuria, epistaxis, gingival bleed
• IC bleed- headache, irritability, drowsiness, coma
Failure of entire RES. No extramedullary
hematopoesis
No
Hepato
megaly
Lympha
denopa
thy
Spleno
megaly
Blood picture:
• Anemia-normocytic, normochromic
• Leukopenia (neutropenia)
• Relative lymphocytosis
• Thrombocytopenia
• Absolute reticulocyte count low
• Mild to moderate anisopoikilocytosis
Other investigations
• BM : dry aspirate, hypocellular with fat (>70%
yellow marrow)
SEVERITY
SEVERE APLASTIC ANEMIA
• Granulocyte count <500/cu.mm
• Platelet count <20,000/cu.mm
• Reticulocytes <1%
• BM < 25% of hematopoeitic cells
VERY SEVERE/ EXTREME APLASTIC ANEMIA
• Above + Granulocyte count <200/cu.mm
Table 42.2 Differential Diagnosis of Pancytopenia with a Hypocellular Bone Marrow
Acquired aplastic anemia
Inherited aplastic anemia
Fanconi anemia
Dyskeratosis congenital
Shwachman-Diamond syndrome
Amegakaryocytic thrombocytopenia
Reticular dysgenesis
Hypoplastic myelodysplastic syndromes
Large granular lymphocytic leukemia (rare)
Hypoplastic PNH (PNH/aplastic anemia)
DIFFERENTIAL DIAGNOSIS
• ALL/AML
• Human Herpesvirus 6 Infection
• Megaloblastic Anemia
• Multiple Myeloma
• Myelodysplastic Syndrome
• Non-Hodgkin Lymphoma
• Osteopetrosis
• Paroxysmal Nocturnal Hemoglobinuria
• Primary Myelofibrosis
• The following tests aid in determining
differential diagnosis for aplastic anemia:-
1)Bone marrow aspirate and biopsy: to rule out
other causes of pancytopenia (i.e. neoplastic
infiltration or significant myelofibrosis).
2)History of iatrogenic exposure
to cytotoxic chemotherapy: can cause transient
bone marrow suppression
3)X-rays, computed tomography (CT) scans, or
ultrasound imaging tests: enlarged lymph nodes
(sign of lymphoma), kidneys and bones in arms
and hands (abnormal in Fanconi anemia)
4)Chest X-ray: infections
5)Liver tests: liver diseases
6)Viral studies: viral infections
7)Vitamin B12 and folate levels: vitamin deficiency
8)Blood tests for paroxysmal nocturnal hemoglobinuria
9)Test for antibodies: immune competency
Concomitant factor
• High incidence of concomitant clonal
hematopoiesis, particularly paroxysmal
nocturnal hemoglobinuria (PNH) and MDS.
• The percentage of CD34+ cells is usually <0.3%
in aplastic anemia, whereas the CD34
percentage is either normal (0.5 to 1.0 %) or
elevated in MDS.
• Peripheral blood flow cytometry to rule out
PNH should be performed on all patients.
Management:
• Identification and elimination of underlying
cause
• Supportive therapy:
1. Red cell transfusion for anemia
2. Prevention and treatment of haemorrhage
3. Prevention and treatment of infection
THERAPY
DEFINITIVE
• BONE MARROW TRANSPLANTATION
• IMMUNOSUPPRESSION
BONE MARROW TRANSPLANTATION
• Treatment of choice
• HLA matched donor. Usually siblings
• Long term survival rates: 60-70%
• Donor stem cells > 4 X 108 cells/kg
IMMUNOSUPPRESSION
• Antithymocyte globulin (ATG)
• Antilymphocyte glubulin (ALG)
• Cyclosporin
• Intensive immunosupression :
cyclophosphamide
• Corticosteroids
Kindly Leave a message if
you like the presentation
and follow for further
updates.
Aplastic anaemia

Aplastic anaemia

  • 1.
  • 2.
    APLASTIC ANEMIA • Reductionin the amount of haemotopoietic tissue causing inability to produce mature cells for discharge into the bloodstream.
  • 3.
    CLASSIFICATION • Idiopathic • Secondary: idiosyncraticdrug reaction chemical exposure infectious hepatitis paroxysmal nocturnal haemoglobinuria • Constitutional
  • 4.
    CLASSIFICATION CONSTITUTIONAL/CONGENITAL • Fanconi anemia •Dyskeratosis Congenita • Shwachmann-Diamond syndrome • Inherited amegakaryocytic thrombocytopenia
  • 5.
    FANCONI ANEMIA • Familial •AR • M:F=1.3:1 • Onset in 1st decade of life • Diminished capacity for DNA repair and increased random chromosome breakage during mitosis
  • 6.
    C/F: • Facies –microphthalmia,depressed nasal bridge,epicanthic fold,micrognathia • Hyperpigmentation, café-au-lait spots • Absent / hypoplastic thumb • Skeletal and renal lesions • Short stature, • Microcephaly , subnormal intelligence • Hypogonadism,ano malies of urinary tract • Predisposition to leukemias • Poor prognosis
  • 7.
    DYSKERATOSIS CONGENITA • X-linked,AR, AD • M:F= 4.3:1 • Hyperpigmentation • Nail dystrophy, early loss of teeth • Leukoplakia • Ocular abnormalities: cataract etc • Short stature but No skeletal/renal lesions (diff from FA)
  • 8.
    DIAMOND BLACKFAN SYNDROME •Congenital pure red cell aplasia • AD, AR, Sporadic • Familial in 15 % • 90 % diagnosed in 1st year of life • Intrinsic defect in RBC, early apoptosis • Macrocytic anemia, reticulocytopenia, absence of RBC precursors in an otherwise normocellular bone marrow
  • 9.
    DIAMOND BLACKFAN SYNDROME •Eye - Wide set eyes, blue sclera,glaucoma,epicanthic fold,cataract,strabismus • Thick upper,cleft lip palate in some cases • lip,intelligent expression • Upperlimb anomalies – flattening of thenar eminence, Triphalangeal thumb
  • 10.
    C/F: • Profound anemiaat 2-6 months of age • Short stature • Renal anomalies and hypogonadism maybe present
  • 11.
    ACQUIRED APLASTIC ANEMIA- CAUSES • Radiation • Drugs and chemicals - chemotherapy - benzene - chloramphenicol - antiepileptics • Viruses: - CMV - EBV - Hep B, C,D - HIV • Immune diseases: - eosinophilic fascitis - thymoma • Pregnancy • PNH • Marrow replacement: - leukemia - myelofibrosis - myelodysplasia
  • 12.
    PATHOPHYSIOLOGY • Direct destructionof hematopoietic progenitors • Disruption of marrow micro-environment (fibroblast and monocyte signaling pathway) • Immune –mediated suppression of marrow elements Cytotoxic T cells in blood and marrow release gamma IFN and TNF -> inhibit early and late progenitor cells
  • 13.
    Pathology: • Hallmark: peripheralpancytopenia with hypoplastic/ aplastic bone marrow
  • 14.
    CLINICAL FEATURES RBC (anemia) •Progressive and persistent pallor • Anemia related symptoms WBC (Leucopenia/neutropenia) • Prone to infections - Pyodermas, OM, pneumonia, UTI, GI infections, sepsis Platelets (Thrombocytopenia) • Petechiae, purpura, ecchymoses • Hematemesis, hematuria, epistaxis, gingival bleed • IC bleed- headache, irritability, drowsiness, coma
  • 15.
    Failure of entireRES. No extramedullary hematopoesis No Hepato megaly Lympha denopa thy Spleno megaly
  • 16.
    Blood picture: • Anemia-normocytic,normochromic • Leukopenia (neutropenia) • Relative lymphocytosis • Thrombocytopenia • Absolute reticulocyte count low • Mild to moderate anisopoikilocytosis
  • 18.
    Other investigations • BM: dry aspirate, hypocellular with fat (>70% yellow marrow)
  • 19.
    SEVERITY SEVERE APLASTIC ANEMIA •Granulocyte count <500/cu.mm • Platelet count <20,000/cu.mm • Reticulocytes <1% • BM < 25% of hematopoeitic cells VERY SEVERE/ EXTREME APLASTIC ANEMIA • Above + Granulocyte count <200/cu.mm
  • 20.
    Table 42.2 DifferentialDiagnosis of Pancytopenia with a Hypocellular Bone Marrow Acquired aplastic anemia Inherited aplastic anemia Fanconi anemia Dyskeratosis congenital Shwachman-Diamond syndrome Amegakaryocytic thrombocytopenia Reticular dysgenesis Hypoplastic myelodysplastic syndromes Large granular lymphocytic leukemia (rare) Hypoplastic PNH (PNH/aplastic anemia)
  • 21.
    DIFFERENTIAL DIAGNOSIS • ALL/AML •Human Herpesvirus 6 Infection • Megaloblastic Anemia • Multiple Myeloma • Myelodysplastic Syndrome • Non-Hodgkin Lymphoma • Osteopetrosis • Paroxysmal Nocturnal Hemoglobinuria • Primary Myelofibrosis
  • 22.
    • The followingtests aid in determining differential diagnosis for aplastic anemia:- 1)Bone marrow aspirate and biopsy: to rule out other causes of pancytopenia (i.e. neoplastic infiltration or significant myelofibrosis). 2)History of iatrogenic exposure to cytotoxic chemotherapy: can cause transient bone marrow suppression 3)X-rays, computed tomography (CT) scans, or ultrasound imaging tests: enlarged lymph nodes (sign of lymphoma), kidneys and bones in arms and hands (abnormal in Fanconi anemia)
  • 23.
    4)Chest X-ray: infections 5)Livertests: liver diseases 6)Viral studies: viral infections 7)Vitamin B12 and folate levels: vitamin deficiency 8)Blood tests for paroxysmal nocturnal hemoglobinuria 9)Test for antibodies: immune competency
  • 24.
    Concomitant factor • Highincidence of concomitant clonal hematopoiesis, particularly paroxysmal nocturnal hemoglobinuria (PNH) and MDS.
  • 26.
    • The percentageof CD34+ cells is usually <0.3% in aplastic anemia, whereas the CD34 percentage is either normal (0.5 to 1.0 %) or elevated in MDS. • Peripheral blood flow cytometry to rule out PNH should be performed on all patients.
  • 27.
    Management: • Identification andelimination of underlying cause • Supportive therapy: 1. Red cell transfusion for anemia 2. Prevention and treatment of haemorrhage 3. Prevention and treatment of infection
  • 28.
    THERAPY DEFINITIVE • BONE MARROWTRANSPLANTATION • IMMUNOSUPPRESSION
  • 29.
    BONE MARROW TRANSPLANTATION •Treatment of choice • HLA matched donor. Usually siblings • Long term survival rates: 60-70% • Donor stem cells > 4 X 108 cells/kg
  • 30.
    IMMUNOSUPPRESSION • Antithymocyte globulin(ATG) • Antilymphocyte glubulin (ALG) • Cyclosporin • Intensive immunosupression : cyclophosphamide • Corticosteroids
  • 31.
    Kindly Leave amessage if you like the presentation and follow for further updates.